Tetanus

Current Anaesthesia and Critical Care

Volumn 16, Issue 1, 2005, Pages 50-57

  Thwaites, C Louise ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPIVACAINE; CHLORPROMAZINE; CLONIDINE; DANTROLENE; DIAZEPAM; ENDOPEPTIDASE INHIBITOR; ENZYME INHIBITOR; ESMOLOL; HUMAN IMMUNOGLOBULIN; LABETOLOL; MAGNESIUM; MAGNESIUM SULFATE; METRONIDAZOLE; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; PHENOBARBITAL; PIPECURONIUM; PROPOFOL; TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXOID; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG; VECURONIUM; ZINC;

AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CLOSTRIDIUM TETANI; DEEP VEIN THROMBOSIS; DISEASE CONTROL; DISEASE SEVERITY; DRUG ABUSE; DRUG MECHANISM; GASTROINTESTINAL HEMORRHAGE; GERIATRIC CARE; HEART ARREST; HOSPITAL INFECTION; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; LUNG EMBOLISM; MORBIDITY; MORTALITY; MUSCLE SPASM; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; TETANUS; TETANUS PROPHYLAXIS;

EID: 19644386726     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2005.01.001     Document Type: Article

References (79)

1. Health Protection Agency. Ongoing national outbreak of tetanus in injecting drug users. Commun Dis Rep CDR Wkly [serial online] 2004;14(9): http://www.hpa.org.uk/cdr/PDFfiles/2004/cdr0904.pdf
2. J.H. Breasted The Edwin Smith surgical papyrus 1930 University of Chicago Press Chicago
3. F.E. Udwadia Tetanus 1994 Oxford University Press New York
4. K. Keja C. Chan G. Hayden R.H. Henderson Expanded programme on immunization World Health Stat Q 41 2 1988 59-63
5. WHO. WHO vaccine-preventable diseases: Monitoring system. Report No.: WHO/V&B/01.34. Geneva: World Health Organization; 2001.
6. C.L. Thwaites J.J. Farrar Preventing and treating tetanus Br Med J 326 7381 2003 117-118
7. J.P. Stanfield A. Galazka Neonatal tetanus in the world today Bull World Health Organ 62 4 1984 647-669
8. I. Sanada S. Nishida Isolation of clostridium tetani from soil J Bacteriol 89 1965 626-629
9. A.A. Rushdy J.M. White M.E. Ramsay N.S. Crowcroft Tetanus in England and Wales, 1984-2000 Epidemiol Infect 130 1 2003 71-77
10. Centre HCDS. NOIDS Midi Report for 2003. Statutory Notifications of Infectious Diseases in England and Wales.
11. S.L. Groseclose W.S. Brathwaite P.A. Hall F.J. Connor P. Sharp W.J. Anderson et al. Summary of notifiable diseases - United States, 2002 MMWR Morb Mortal Wkly Rep 51 53 2004 1-84
12. G.M. McQuillan D. Kruszon-Moran A. Deforest S.Y. Chu M. Wharton Serologic immunity to diphtheria and tetanus in the United States Ann Intern Med 136 9 2002 660-666
13. M.I. de Moraes-Pinto A.C. Almeida G. Kenj T.E. Filgueiras W. Tobias A.M. Santos et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection J Infect Dis 173 5 1996 1077-1084
14. M.E. Brair B.J. Brabin P. Milligan S. Maxwell C.A. Hart Reduced transfer of tetanus antibodies with placental malaria Lancet 343 8891 1994 208-209
15. M.I. de Moraes-Pinto R.S. Oruamabo F.P. Igbagiri M.C. Chan S.M. Prado M.D. Vancetto et al. Neonatal tetanus despite immunization and protective antitoxin antibody J Infect Dis 171 4 1995 1076-1077
16. Salisbury DM, Begg NT. Tetanus. In: Immunisation against infectious diseases (The green book), 1996. http://www.doh.gov.uk/greenbook/ greenbookpdf-chapter-30-layout.pdf
17. O.C. Cassell A.J. Fitton W.A. Dickson M.A. Milling An audit of the tetanus immunisation status of plastic surgery trauma and burns patients Br J Plast Surg 55 3 2002 215-218
18. A. Montague E. Glucksman Influences on tetanus immunization in accident and emergency Arch Emerg Med 7 3 1990 163-168
19. O.J. Fatunde J.B. Familusi Deficiencies in tetanus prophylaxis in wound management in Ibadan, Nigeria West Afr J Med 21 2 2002 105-107
20. C.L. Thwaites L.M. Yen N.T.N. Nga et al. Impact of improved vaccination programme and intensive care facilities and outcome of tetanus in southern Vietnam, 1993-2002 T Roy Soc Trop Med H 98 11 2004 671-677
21. U. Eisel W. Jarausch K. Goretzki A. Henschen J. Engels U. Weller et al. Tetanus toxin: Primary structure, expression in E. coli, and homology with botulinum toxins EMBO J 5 10 1986 2495-2502
22. H. Bruggemann S. Baumer W.F. Fricke A. Wiezer H. Liesegang I. Decker et al. The genome sequence of Clostridium tetani, the causative agent of tetanus disease Proc Natl Acad Sci U S A 100 3 2003 1316-1321
23. U. Weller M.E. Dauzenroth D. Meyer zu Heringdorf E. Habermann Chains and fragments of tetanus toxin. Separation, reassociation and pharmacological properties Eur J Biochem 182 3 1989 649-656
24. Y. Humeau F. Doussau N.J. Grant B. Poulain How botulinum and tetanus neurotoxins block neurotransmitter release Biochimie 82 5 2000 427-446
25. G. Lalli S. Bohnert K. Deinhardt C. Verastegui G. Schiavo The journey of tetanus and botulinum neurotoxins in neurons Trends Microbiol 11 9 2003 431-437
26. J. Herreros G. Lalli C. Montecucco G. Schiavo Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons J Neurochem 74 5 2000 1941-1950
27. D.J. De Michele A.M. Taveira Da Silva Cardiovascular findings in a patient with severe tetanus Crit Care Med 11 10 1983 828-829
28. R.S. Edmondson M.W. Flowers Intensive care in tetanus: Management, complications, and mortality in 100 cases Br Med J 1 6175 1979 1401-1404
29. T.M. Cook R.T. Protheroe J.M. Handel Tetanus: A review of the literature Br J Anaesth 87 3 2001 477-487
30. S.R. Kelty R.C. Gray J.W. Dundee H. McCullouch Catecholamine levels in severe tatanus Lancet 2 7561 1968 195
31. C. Toothill J.R. Dykes J.J. Ablett Urinary catecholamine metabolite concentrations in tetanus Br J Anaesth 42 6 1970 524-530
32. E.F. Daher R.C. Abdulkader E. Motti M. Marcondes E. Sabbaga E.A. Burdmann Prospective study of tetanus-induced acute renal dysfunction: role of adrenergic overactivity Am J Trop Med Hyg 57 5 1997 610-614
33. T.M. Cook Severe anuric renal failure in a patient with tetanus Br J Anaesth 88 5 2002 741
34. A.P. Asherson T.G. Ruttmann Severe anuric renal failure in a patient with tetanus Br J Anaesth 88 5 2002 740-741 author reply 741-2.
35. J.J.L. Ablett Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit In: M. Ellis editor Symposium on tetanus in Great Britain 1967 Leeds General Infirmary Boston Spa, UK 1-10
36. J.C. Patel B.C. Mehta K.N. Modi Prognosis in tetanus In: J.C. Patel editor 1st international conference on tetanus 1963 Bombay: Study Group of Tetanus, King Edward Memorial Hospital 181-201
37. N. Saltoglu Y. Tasova D. Midikli R. Burgut I.H. Dundar Prognostic factors affecting deaths from adult tetanus Clin Microbiol Infect 10 3 2004 229-233
38. P. Armitage R. Clifford Prognosis in tetanus: Use of data from therapeutic trials J Infect Dis 138 1 1978 1-8
39. Vakil BJ. Table ronde: Propositions pour une classification internationale. In: 4th international conference on tetanus; Dakar: Fondation Merieux, Lyons; 1975. p. 3349-67.
40. L.A. Phillips A classification of tetanus Lancet 1 7501 1967 1216-1217
41. D. Attygalle Magnesium sulphate in the management of severe tetanus averts artificial ventilation and sedation Ceylon Med J 41 3 1996 120
42. J.S. Brauner S.R. Vieira T.P. Bleck Changes in severe accidental tetanus mortality in the ICU during two decades in Brazil Intensive Care Med 28 7 2002 930-935
43. J.J. Farrar L.M. Yen T. Cook N. Fairweather N. Binh J. Parry et al. Tetanus J Neurol Neurosurg Psychiatry 69 3 2000 292-301
44. I. Ahmadsyah A. Salim Treatment of tetanus: An open study to compare the efficacy of procaine penicillin and metronidazole Br Med J (Clin Res Ed) 291 6496 1985 648-650
45. C.L. Thwaites Tetanus Practical Neurol 2 3 2002 130-137
46. G.H. McCracken Jr. D.L. Dowell F.N. Marshall Double-blind trial of equine antitoxin and human immune globulin in tetanus neonatorum Lancet 1 7710 1971 1146-1149
47. I. Ildirim Intrathecal serotherapy of tetanus. I. Explanation of complications. II. Comparison of intrathecal tetanus immune globulin and tetanus antitoxin Turk J Pediatr 16 3 1974 103-110
48. E. Abrutyn J.A. Berlin Intrathecal therapy in tetanus. A meta-analysis J Am Med Assoc 266 16 1991 2262-2267
49. B. Miranda-Filho Dde R.A. Ximenes A.A. Barone V.L. Vaz A.G. Vieira V.M. Albuquerque Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route Br Med J 328 7440 2004 615
50. Okoromah CN LF. Diazepam for treating tetanus (Cochrane Review). In: The Cochrane Library. Chichester, UK: Wiley; 2004.
51. Ismoedijanto M. Nassiruddin B.W. Prajitno Case report: Diazepam in severe tetanus treatment Southeast Asian J Trop Med Public Health 35 1 2004 175-180
52. J. Lipman M.F. James J. Erskine M.L. Plit J. Eidelman J.D. Esser Autonomic dysfunction in severe tetanus: Magnesium sulfate as an adjunct to deep sedation Crit Care Med 15 10 1987 987-988
53. A. Borgeat V. Popovic D. Schwander Efficiency of a continuous infusion of propofol in a patient with tetanus Crit Care Med 19 2 1991 295-297
54. V.A. Peduto G.M. Pisanu M. Piga Midazolam, propofol, and clonidine for sedation and control of autonomic dysfunction in severe generalized tetanus Minerva Anestesiol 59 4 1993 171-178 [in Italian]
55. J.H. Kerr J.L. Corbett J.M. Spalding Sympathetic overactivity in severe tetanus Proc R Soc Med 62 7 1969 659-662
56. A. Fassoulaki M. Eforakopoulou Vecuronium in the management of tetanus. Is it the muscle relaxant of choice Acta Anaesthesiol Belg 39 2 1988 75-78
57. N. Buchanan R.D. Cane G. Wolfson M. De Andrade Autonomic dysfunction in tetanus: The effects of a variety of therapeutic agents, with special reference to morphine Intensive Care Med 5 2 1979 65-68
58. M.L. Santos A. Mota-Miranda A. Alves-Pereira A. Gomes J. Correia N. Marcal Intrathecal baclofen for the treatment of tetanus Clin Infect Dis 38 3 2004 321-328
59. M.F. James R.E. Beer J.D. Esser Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation Anesth Analg 68 6 1989 772-776
60. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels Can J Physiol Pharmacol 65 4 1987 729-745
61. D. Attygalle N. Rodrigo Magnesium as first line therapy in the management of tetanus: A prospective study of 40 patients Anaesthesia 57 8 2002 811-817
62. M.F. James E.D. Manson The use of magnesium sulphate infusions in the management of very severe tetanus Intensive Care Med 11 1 1985 5-12
63. D.A. Rocke A.G. Wesley M. Pather A.D. Calver D. Hariparsad Morphine in tetanus - the management of sympathetic nervous system overactivity S Afr Med J 70 11 1986 666-668
64. M.A. Rie R.S. Wilson Morphine therapy controls autonomic hyperactivity in tetanus Ann Intern Med 88 5 1978 653-654
65. S. Bhagwanjee A.T. Bosenberg D.J. Muckart Management of sympathetic overactivity in tetanus with epidural bupivacaine and sufentanil: experience with 11 patients Crit Care Med 27 9 1999 1721-1725
66. P.A. Southorn G.A. Blaise Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade Crit Care Med 14 3 1986 251-252
67. N. Buchanan L. Smit R.D. Cane M. De Andrade Sympathetic overactivity in tetanus: Fatality associated with propranolol Br Med J 2 6132 1978 254-255
68. A.G. Wesley D. Hariparsad M. Pather D.A. Rocke Labetalol in tetanus The treatment of sympathetic nervous system overactivity. Anaesthesia 38 3 1983 243-249
69. W.W. King D.R. Cave Use of esmolol to control autonomic instability of tetanus Am J Med 91 4 1991 425-428
70. N.J. Cavalcante M.L. Sandeville E.A. Medeiros Incidence of and risk factors for nosocomial pneumonia in patients with tetanus Clin Infect Dis 33 11 2001 1842-1846
71. T.P. Bleck Tetanus: Pathophysiology, management, and prophylaxis Dis Mon 37 9 1991 545-603
72. D.R. Curtis W.C. De Groat Tetanus toxin and spinal inhibition Brain Res 10 2 1968 208-212
73. L.S. Illis F.M. Taylor Neurological and electroencephalographic sequelae of tetanus Lancet 1 7704 1971 826-830
74. B. Anlar K. Yalaz R. Dizmen Long-term prognosis after neonatal tetanus Dev Med Child Neurol 31 1 1989 76-80
75. P. Teknetzi S. Manios V. Katsouyanopoulos Neonatal tetanus - long-term residual handicaps Arch Dis Child 58 1 1983 68-69
76. M. Lindley-Jones D. Lewis J.L. Southgate Recurrent tetanus Lancet 363 9426 2004 2048
77. L.L. Simpson J.A. Coffield N. Bakry Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin J Pharmacol Exp Ther 267 2 1993 720-727
78. (2+) -dependent protease activity is removed J Biol Chem 270 52 1995 31386-31390
79. Martin L, Cornille F, Turcaud S, Meudal H, Roques BP, Fourni-Zaluski MC. Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach. J. Med. Chem. 1999; 43(3)515-25.